Singh Shawn Insider Trades

Insider Trading History

Track insider trading activity for Singh Shawn. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vistagen Therapeutics
Vistagen Therapeutics VTGN
President And CEO
Holding Value $41k 71,268 shares
Last Trade
Apr 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.5k 75,000 shares
$0.54
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
President And CEO
Holding Value $10.4k 18,028 shares
Last Trade
Jun 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.1k 7,541 shares
$2.00
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
President And CEO
Holding Value $173k 300,000 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$588k 300,000 shares
$1.96
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $6.04k 10,487 shares
Last Trade
Jun 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.9k 4,854 shares
$3.48
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $288k 500,000 shares
Last Trade
Jun 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.62M 500,000 shares
$3.23
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $3.24k 5,633 shares
Last Trade
Dec 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$858 167 shares
$5.14
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $3.15k 5,466 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$312 167 shares
$1.87
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
Director, CHIEF EXECUTIVE OFFICER
Holding Value $91.5k 158,998 shares
Last Trade
Dec 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$464k 5,000 shares
$92.70
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
Director, CHIEF EXECUTIVE OFFICER
Holding Value $360k 626,234 shares
Last Trade
Aug 17, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$104M 600,000 shares
$173.79
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
Director, CHIEF EXECUTIVE OFFICER
Holding Value $88.6k 153,998 shares
Last Trade
Jun 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.96M 5,000 shares
$792.00
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
Director, CHIEF EXECUTIVE OFFICER
Holding Value $85.8k 148,998 shares
Last Trade
May 12, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$99M 100,000 shares
$990.00
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $173k 300,000 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$370M 300,000 shares
$1,233.00
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $28.2k 48,998 shares
Last Trade
Dec 31, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.36M 3,623 shares
$1,755.00
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $26.1k 45,375 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.2M 5,000 shares
$2,835.00
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $0 0 shares
Last Trade
Apr 23, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.18M 5,000 shares
$1,836.00
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $23.2k 40,375 shares
Last Trade
Apr 23, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.18M 5,000 shares
$1,836.00
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $20.4k 35,375 shares
Last Trade
Dec 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.73M 5,000 shares
$1,746.00
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $173k 300,000 shares
Last Trade
Dec 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$478M 300,000 shares
$1,593.00
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $17.5k 30,375 shares
Last Trade
Jun 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.37M 5,000 shares
$474.39
$0.58
Vistagen Therapeutics
Vistagen Therapeutics VTGN
CHIEF EXECUTIVE OFFICER
Holding Value $173k 300,000 shares
Last Trade
Apr 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107M 300,000 shares
$358.20
$0.58

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up